Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
REUN
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.20
N/A
-1.15
vs -0.14
Q1.21
N/A
-1.30
vs -1.10
Q2.21
N/A
-0.23
vs -0.90
Q3.21
N/A
-0.92
vs -1.15
Q4.21
N/A
-1.29
vs -1.15
Q1.22
N/A
-0.43
vs -1.30
Q2.22
N/A
-0.41
vs -0.23
Q3.22
N/A
-2.05
vs -0.92
Q4.22
N/A
-1.09
vs -1.29
Q1.23
N/A
-0.54
vs -0.43
Sales Growth
YoY
Current
Estimates
Q4.20
NA
316.3K vs NA
Q1.21
+52544%
526.4K vs 1K
Q2.21
+3576%
867.4K vs 23.6K
Q3.21
+860%
907.8K vs 94.5K
Q4.21
+330%
1.4M vs 316.3K
Q1.22
+228%
1.7M vs 526.4K
Q2.22
-100%
NA vs 867.4K
Q3.22
-100%
NA vs 907.8K
Q4.22
-100%
NA vs 1.4M
Q1.23
-100%
NA vs 1.7M
Return on Equity
QoQ
Q2.21
-12%
-0.12
vs -0.07
Q3.21
-14%
-0.14
vs -0.12
Q4.21
-19%
-0.19
vs -0.14
Q1.22
-21%
-0.21
vs -0.19
Q2.22
-25%
-0.25
vs -0.21
Q3.22
-42%
-0.42
vs -0.25
Q4.22
-47%
-0.47
vs -0.42
Q1.23
-30%
-0.30
vs -0.47
Institutionnal Ownership
QoQ
Q3.22
19
19
vs NA
NA
Q4.22
25
25
vs 19
32%
Q1.23
25
25
vs 25
NA
Q2.23
20
20
vs 25
-20%
globenewswire.com
7 hours ago
globenewswire.com
7 hours ago
globenewswire.com
7 hours ago
Quote Panel
Key Metrics
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.
NASDAQ
Unprofitable
Unprofitable
-0.01Â ( -0.89%)
Relative Strenght
92
Volume Buzz
-96%
Earning Acce
Yes
Dist 52w H.
95%Relative Strength
REUN
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available